BindingDB logo
myBDB logout

BDBM260213 US9522914, A-15

SMILES: COc1cc(ccc1F)-c1nc(cn1CC(=O)NC(C)C)-c1ccc(CCN2C3CCC2CC(O)C3)cc1

InChI Key: InChIKey=PRGLVTYMUBVODA-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 260213   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Vasopressin V1b receptor


(Homo sapiens (Human))
BDBM260213
PNG
(US9522914, A-15)
Show SMILES COc1cc(ccc1F)-c1nc(cn1CC(=O)NC(C)C)-c1ccc(CCN2C3CCC2CC(O)C3)cc1 |THB:34:33:27:29.30|
Show InChI InChI=1S/C30H37FN4O3/c1-19(2)32-29(37)18-34-17-27(33-30(34)22-8-11-26(31)28(14-22)38-3)21-6-4-20(5-7-21)12-13-35-23-9-10-24(35)16-25(36)15-23/h4-8,11,14,17,19,23-25,36H,9-10,12-13,15-16,18H2,1-3H3,(H,32,37)
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.40n/an/an/an/a7.425



TAISHO PHARMACEUTICAL CO., LTD

US Patent


Assay Description
Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...


US Patent US9522914 (2016)


BindingDB Entry DOI: 10.7270/Q2KS6PR7
More data for this
Ligand-Target Pair
Vasopressin V1b receptor


(Homo sapiens (Human))
BDBM260213
PNG
(US9522914, A-15)
Show SMILES COc1cc(ccc1F)-c1nc(cn1CC(=O)NC(C)C)-c1ccc(CCN2C3CCC2CC(O)C3)cc1 |THB:34:33:27:29.30|
Show InChI InChI=1S/C30H37FN4O3/c1-19(2)32-29(37)18-34-17-27(33-30(34)22-8-11-26(31)28(14-22)38-3)21-6-4-20(5-7-21)12-13-35-23-9-10-24(35)16-25(36)15-23/h4-8,11,14,17,19,23-25,36H,9-10,12-13,15-16,18H2,1-3H3,(H,32,37)
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.40n/an/an/an/a7.44



TAISHO PHARMACEUTICAL CO., LTD

US Patent


Assay Description
Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo...


US Patent US9522914 (2016)


BindingDB Entry DOI: 10.7270/Q2WM1CB9
More data for this
Ligand-Target Pair